Embleema

Hospitals and Health CareUnited States11-50 Employees

Embleema accelerates precision medicine by unifying clinical, molecular, and real-world data to generate regulatory-grade evidence. The FDA uses our platform for genomic regulatory evaluations, Project ARGOS, and to help shape future CDISC standards for cell and gene therapies. We also power landmark studies like the Lupus Landmark Study, the Human Epilepsy Project, and dozens of trials for pharma, biotechs, and patient groups. We work with more than half of the top U.S. research sites, including Johns Hopkins, NYU, UCSF, Yale, and Mayo Clinic.

Sign up for free to view info

Email Format Employee directory